| 1. |
2024
Chen SM,Chen LY,Lin JH,Nicole Salazar,Yeh TH,Lo WL, Lui TN, Hsieh YC, Chien LN.
Comparison of endoscopic third ventriculostomy versus cerebrospinal fluid shunt procedures for the treatment of pediatric hydrocephalus in Taiwan
. Child's nervous system
.2024
|
|
| 2. |
2023
Ko TH,Lee YH,Chen L,Tsai WK,Hong CT,Lo WL.
Magnetic Resonance-Guided focused ultrasound surgery for Parkinson's disease: A mini-review and comparison between deep brain stimulation
. Parkinsonism Related Disorder
.2023
|
|
| 3. |
2022
Yu-Ting Tsai,Wei-Lun Lo,Pin-Yuan Chen,Chiung-Yuan Ko,Jian-Ying Chuang,Tzu-Jen Kao, Wen-Bing Yang, Kwang-Yu Chang, Chia-Yang Hung, Ushio Kikkawa, Wen-Chang Chang & Tsung-I. Hsu.
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
. Journal of Biomedical Science
.2022
|
|
| 4. |
2022
Lin MC,Liu HW,Su YK,Lo WL,Lin CM.
Robot-guided versus freehand fluoroscopy-guided minimally invasive transforaminal lumbar interbody fusion: a single-institution, observational, case-control study
. Neurosurgical Focus
.2022
;(52)
|
|
| 5. |
2021
Tao-Chieh Yang,Shih-Jung Liu,Wei-Lun Lo ,Shu-Mei Chen ,Ya-Ling Tang,Yuan-Yun Tseng .
Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle
. International journal of molecular sciences
.2021
;(22)
|
|
| 6. |
2021
Yu-Ting Tsai ,Chung-Che Wu ,Chiung-Yuan Ko,Tsung-I Hsu,Wen-Chang Chang,Wei-Lun Lo, Jian-Ying Chuang .
Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis
. Biochemical and biophysical research communications
.2021
;(550):113-119
|
|
| 7. |
2021
Yang WB,Wu AC ,Hsu TI ,Liou JP ,Lo WL ,Chang KY, Chen PY, Kikkawa U, Yang ST, Kao TJ, Chen RM, Chang WC, Ko CY, Chuang CY.
Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells
. Cell death & disease
.2021
;(12)
|
|
| 8. |
2020
Lo WL,Hsu TI,Yang WB ,Kao TJ,Wu MH ,Huang YN, Yeh SH, Chuang JY.
Betulinic Acid-Mediated Tuning of PERK/CHOP Signaling by Sp1 Inhibition as a Novel Therapeutic Strategy for Glioblastoma
. Cancers (Basel)
.2020
;(12)
|
|
| 9. |
2019
Lin HY,Ko CY,Kao TJ ,Yang WB ,Tsai YT,Chuang JY, Hu SL, Yang PY, Lo WL, Hsu TI.
CYP17A1 Maintains the Survival of Glioblastomas by Regulating SAR1-Mediated Endoplasmic Reticulum Health and Redox Homeostasis
. Cancers (Basel)
.2019
;(11)
|
|
| 10. |
2019
Chien CH,Chuang JY,Yang ST ,Yang WB ,Chen PY ,Hsu TI, Huang CY, Lo WL, Yang KY, Liu MS, Chu JM, Chung PH, Liu JJ, Chou SW, Chen SH, Chang KY.
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
. Journal of biomedical science
.2019
;(26)
|
|
| 11. |
2018
Lin CY,Yang ST,Shen SC,Hsieh YC,Hsu FT,Chen CY, Chiang YH, Chuang JY, Chen KY, Hsu TI, Leong WC, Su YK, Lo WL, Yeh YS, Patria YN, Shih HM, Chang CC, Chou SY.
Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression.
. Molecular Oncology
.2018
;(12):756-771
|
|
| 12. |
2017
Chuang JY,Lo WL,Ko CY,Chou SY,Chen RM,Chang KY, Hung JJ, Su WC, Chang WC, Hsu TI.
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma
. Oncogenesis
.2017
;(6)
|
|
| 13. |
2017
Sharim J,Lo WL,Kim W,Chivukula S,Tenn S,Kaprealian T, Pouratian N.
Radiosurgical Target Distance from the Root Entry Zone in the Treatment of Trigeminal Neuralgia
. Practical Radiation Oncology
.2017
;(7):221-227
|
|
| 14. |
2017
Cheng HW,Lo WL,Kuo CY,Su YK,Tsai JT,Lin JW, Wang YJ, Pan HC.
Forward treatment planning techniques to reduce the normalization effect in Gamma Knife radiosurgery
. Journal of applied clinical medical physics
.2017
;(18):114-122
|
|